Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Papatheodoridis

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Journal of Clinical Microbiology|April 16, 2010
CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer diseaseEffrosini G Panayotopoulou, Dionyssios N Sgouras, Konstantinos S Papadakos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2019
Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replicationZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2020
Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analoguesSpilios Manolakopoulos, Hariklia Kranidioti, Anastasia Kourikou, et al.
Plos One|February 25, 2009
A novel immunological assay for hepcidin quantification in human serumVasiliki Koliaraki, Martha Marinou, Theodoros P Vassilakopoulos, et al.
Journal of Hepatology|July 21, 2009
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertensionSpilios Manolakopoulos, Christos Triantos, Jiannis Theodoropoulos, et al.
Expert Review of Vaccines|May 13, 2025
Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunitiesMaria Buti, Paolo Bonanni, Nimzing Ladep, et al.
European Journal of Gastroenterology & Hepatology|June 20, 2017
Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest painNikos Viazis, Konstantina Katopodi, George Karamanolis, et al.
Journal of Hepatology|July 16, 2013
Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective studyEmanuel K Manesis, Georgia Vourli, George Dalekos, et al.
BMC Public Health|November 6, 2022
Hepatitis B, C and human immunodeficiency virus knowledge among the general greek population: results from the Hprolipsis nationwide surveySylvia Kaskafetou, Argiro Karakosta, Vana Sypsa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 5, 2014
On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patientsIoannis Goulis, Stylianos Karatapanis, Evangelos Akriviadis, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Journal of Clinical Microbiology|April 16, 2010
CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer diseaseEffrosini G Panayotopoulou, Dionyssios N Sgouras, Konstantinos S Papadakos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2019
Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replicationZobair M Younossi, Maria Stepanova, Issah Younossi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2020
Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analoguesSpilios Manolakopoulos, Hariklia Kranidioti, Anastasia Kourikou, et al.
Plos One|February 25, 2009
A novel immunological assay for hepcidin quantification in human serumVasiliki Koliaraki, Martha Marinou, Theodoros P Vassilakopoulos, et al.
Journal of Hepatology|July 21, 2009
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertensionSpilios Manolakopoulos, Christos Triantos, Jiannis Theodoropoulos, et al.
Expert Review of Vaccines|May 13, 2025
Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunitiesMaria Buti, Paolo Bonanni, Nimzing Ladep, et al.
European Journal of Gastroenterology & Hepatology|June 20, 2017
Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest painNikos Viazis, Konstantina Katopodi, George Karamanolis, et al.
Journal of Hepatology|July 16, 2013
Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective studyEmanuel K Manesis, Georgia Vourli, George Dalekos, et al.
BMC Public Health|November 6, 2022
Hepatitis B, C and human immunodeficiency virus knowledge among the general greek population: results from the Hprolipsis nationwide surveySylvia Kaskafetou, Argiro Karakosta, Vana Sypsa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 5, 2014
On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patientsIoannis Goulis, Stylianos Karatapanis, Evangelos Akriviadis, et al.
Pageof 14